| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.59 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |